Recording

The Hidden Gem of GxP AI: What Will Define 2025 and How to Stay Ahead

The event is finished.

Date

Jan 29 2025
Expired!

Time
4:00 PM – 5:30 PM, Central European Time (CET)
10:00 AM – 11:30 AM, Eastern Time (ET)

Overview

Unlock the Future of Pharma Manufacturing with AI!

Join us for an exclusive webinar to discover how cutting-edge AI technologies are set to transform the landscape of pharmaceutical manufacturing in GMP environments.

Why Attend?

In today’s fast-paced pharma industry, understanding the implications of AI is crucial for staying competitive. Join a panel of seasoned industry leaders, including Aizon’s executive team, for a comprehensive view of the opportunities that AI presents in pharma manufacturing. Explore the trends and technologies that will shape 2025 and beyond.

What You Will Gain

  • Comprehensive Insights: Understand the role of AI in transforming GMP processes and what to expect in 2025.
  • Strategic Pathways: Learn how to define your North Star and identify the fastest paths to success while overcoming potential roadblocks.
  • Real-World Examples: See actual case studies showcasing how AI is revolutionizing pharma manufacturing.

Speakers

– Pep Gubau: CEO and Co-founder of Aizon, will offer an industry perspective on AI’s impact, emphasizing the shift towards productivity and quality in manufacturing.

– Toni Manzano: Co-founder and Chief Science Officer at Aizon, will provide scientific insights on AI in pharma manufacturing, discussing lifecycle applications, regulatory readiness, and the potential of digital twins.

– Kevin Baughan: VP of Aizon Consulting Services, will share real-world use cases and success stories, highlighting AI’s tangible benefits in pharma.

Equip yourself and your organization with the tools needed to thrive in an evolving market and gain valuable insights that can directly impact your operations.

Don’t miss out on this opportunity to stay ahead in the GxP AI landscape. Register now and secure your place at this must-attend webinar.

Speakers

  • Pep Gubau
    Pep Gubau
    CEO at Aizon

    Pep Gubau is founder and CEO of Aizon and has been a pharmatech entrepreneur for the last 30 years.

    Pep is an economist with an engineering background and holds several international patents related to the encryption, transmission, storage and processing of data for regulated environments in the cloud. Pep also lectures regularly in Master Programs and gives talks about the business impact of Big Data, Machine Learning and Advanced Analytics.

  • Toni Manzano
    Toni Manzano
    Co-founder and Chief Science Officer of Aizon

    Toni Manzano is a co-founder and Chief Science Officer of Aizon, bringing over two decades of experience in leading software projects for international pharmaceutical companies, with a focus on manufacturing and supply chain optimization.

    Trained as an astrophysicist, Toni has become a recognized expert in Quality and Artificial Intelligence in the pharmaceutical sector, sharing his expertise as a lecturer at several universities. A prolific scientific writer, he holds a dozen international patents and is a member of the PDA Regulatory Affairs & Quality Advisory Board. Toni also actively contributes to the United Nations’ AI initiative.

  • Kevin Baughman
    Kevin Baughman
    VP of Aizon AI Consulting Services

    Kevin Baughman is the VP of Aizon AI Consulting Services where he is responsible for the delivery of value-based solutions that transform customers’ operations by merging technology with strategic vision. He has held multiple customer-facing roles, ultimately landing in consulting specializing in Artificial Intelligence and cloud-based solution integration. As a consultant, he has led projects in both the private and public sector for clients in many industries, including finance, insurance, transportation, healthcare, and pharmaceuticals.

    Kevin attended N.C. State University for both undergraduate and graduate school where he received B.S. degrees in Applied Mathematics and Economics as well as an M.S. degree in Advanced Analytics from the Institute for Advanced Analytics.

    Now at Aizon, Kevin continues to deliver value by working hand-in-hand with customers to co-create, develop, and implement strategic, AI-focused solutions.

Partner

Aizon
Aizon
Website
http://www.aizon.ai

Aizon pioneers Intelligent GxP Manufacturing: eliminate paper, boost yield, cut deviations, and ensure quality with AI, in just a few weeks.

  • Who Should Attend:
    • Industries: Pharma, Biotech and CDMOs.
    • C-level: Chief Technology, Chief Quality, Chief Operations, Chief Executive
    • GxP Professionals: Site Heads, Quality (QA/QC), Process Engineers, TechOps, MSAT, Operational Excellence, Head of Manufacturing, Compliance Officers, Quality Systems Specialists, Validation Engineers, Production Supervisors, Data Scientists.
  • Skill Level: Intermediate
  • Topics:

    1. Gain a comprehensive view of AI in pharma manufacturing with a focus on GMP environments - what will happen in 2025?
    2. Define your North Star and the fastest path to get there while overcoming roadblocks with modern approaches
    3- See real-world examples of AI transforming GMP processes

  • Special event information:

    All participants will get a complimentary certificate of attendance courtesy of the webinar's partner - Aizon.

Date

Jan 29 2025
Expired!

Time
4:00 PM – 5:30 PM, Central European Time (CET)
10:00 AM – 11:30 AM, Eastern Time (ET)

The event is finished.

Speakers

  • Pep Gubau
    Pep Gubau
    CEO at Aizon

    Pep Gubau is founder and CEO of Aizon and has been a pharmatech entrepreneur for the last 30 years.

    Pep is an economist with an engineering background and holds several international patents related to the encryption, transmission, storage and processing of data for regulated environments in the cloud. Pep also lectures regularly in Master Programs and gives talks about the business impact of Big Data, Machine Learning and Advanced Analytics.

  • Toni Manzano
    Toni Manzano
    Co-founder and Chief Science Officer of Aizon

    Toni Manzano is a co-founder and Chief Science Officer of Aizon, bringing over two decades of experience in leading software projects for international pharmaceutical companies, with a focus on manufacturing and supply chain optimization.

    Trained as an astrophysicist, Toni has become a recognized expert in Quality and Artificial Intelligence in the pharmaceutical sector, sharing his expertise as a lecturer at several universities. A prolific scientific writer, he holds a dozen international patents and is a member of the PDA Regulatory Affairs & Quality Advisory Board. Toni also actively contributes to the United Nations’ AI initiative.

  • Kevin Baughman
    Kevin Baughman
    VP of Aizon AI Consulting Services

    Kevin Baughman is the VP of Aizon AI Consulting Services where he is responsible for the delivery of value-based solutions that transform customers’ operations by merging technology with strategic vision. He has held multiple customer-facing roles, ultimately landing in consulting specializing in Artificial Intelligence and cloud-based solution integration. As a consultant, he has led projects in both the private and public sector for clients in many industries, including finance, insurance, transportation, healthcare, and pharmaceuticals.

    Kevin attended N.C. State University for both undergraduate and graduate school where he received B.S. degrees in Applied Mathematics and Economics as well as an M.S. degree in Advanced Analytics from the Institute for Advanced Analytics.

    Now at Aizon, Kevin continues to deliver value by working hand-in-hand with customers to co-create, develop, and implement strategic, AI-focused solutions.

Partner

Aizon
Aizon
Website
http://www.aizon.ai

Aizon pioneers Intelligent GxP Manufacturing: eliminate paper, boost yield, cut deviations, and ensure quality with AI, in just a few weeks.

What people are saying

Love-Mail.png

Weekly Industry Insights &
tips for success

Join thousands of pharma professionals on an enlightening journey. 

Subscribe to our weekly newsletter to stay current with the latest industry trends, compliance and skyrocket your career.